NCT02365597 2026-04-13An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial CancerJanssen Research & Development, LLCPhase 2 Active not recruiting239 enrolled 32 charts 2 FDA
NCT06899061 2026-03-27Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of SaruparibAstraZenecaPhase 1 Active not recruiting41 enrolled